Organogenesis Holdings Inc. (ORGO) has a market capitalization of $322.89M and trades at $2.51. The 52-week range is 2.21-7.077.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 15.7, Earnings Per Share (EPS) of $0.16, annual revenue of $564.17M.
The stock has a beta of 1.48, operates in the Healthcare sector.
